Shares of Health Care sector company Charles River Laboratories International moved -1.4% today, and are now trading at a price of $195.38. The large-cap stock's daily volume was 57,440 compared to its average volume of 476,953. The S&P 500 index returned a 0.0% performance.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The company is based in Wilmington and has 20,000 full time employees. Its market capitalization is $10,017,405,952.
13 analysts are following Charles River Laboratories International and have set target prices ranging from $207.0 to $280.0 per share. On average, they have given the company a rating of buy. At today's prices, CRL is trading -19.37% away from its average analyst target price of $242.31 per share.
Over the last year, CRL's share price has increased by 4.0%, which represents a difference of -14.0% when compared to the S&P 500. The stock's 52 week high is $262.0 per share whereas its 52 week low is $181.22.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-22 | 619,640 | -324,733 | 944,373 | -4.57 |
| 2022-02-16 | 760,799 | -228,772 | 989,571 | 38.76 |
| 2021-02-17 | 546,575 | -166,560 | 713,135 | 14.75 |
| 2020-02-11 | 480,936 | -140,514 | 621,450 | 6.93 |
| 2019-02-13 | 441,140 | -140,054 | 581,194 | 45.12 |
| 2018-02-13 | 318,074 | -82,431 | 400,505 |
